How to Reconstitute Peptides: A Step-by-Step Guide

Introduction#

If a vial of lyophilised peptide is handled carelessly at the mixing stage, every later step in the research workflow inherits that error. This guide covers how to reconstitute peptides from raw powder into a stable, measurable liquid using clean technique, the correct solvent, and a simple volumetric calculation. The process is not difficult, but it is unforgiving: shake a vial too hard, pick the wrong water, or miscalculate a dilution, and the resulting solution can be degraded, contaminated, or simply unknowable in concentration.

Peptide reconstitution is the single most common point of failure in at-home research workflows. Canadian researchers ordering from domestic suppliers such as Lynx Labs receive sealed vials of lyophilised powder that must be mixed with sterile solvent before any dosing work begins. Done correctly, reconstitution takes under five minutes per vial. Done badly, it wastes expensive material and produces dosing figures that no one can trust.

What Reconstitution Actually Is#

Reconstitution is the process of dissolving a lyophilised (freeze-dried) peptide back into an aqueous solution. Peptides ship as powder because the lyophilisation process removes water under vacuum and leaves behind a stable, porous cake that can sit at room temperature for weeks and survive transit from warehouse to research bench without meaningful degradation.

That stability disappears the moment water is introduced. A reconstituted peptide is a solution of fragile protein chains in liquid, and from that point forward it needs cold storage, protection from light, and careful handling. Reconstitution is therefore not just a mixing step: it is the moment a shelf-stable raw material becomes a time-limited research reagent.

The goal of good technique is threefold. First, fully dissolve the powder without denaturing the peptide. Second, produce a solution whose concentration is known with enough precision to calculate accurate doses. Third, do both of those things without introducing microbial contamination.

What You Need (Checklist)#

Before opening a single vial, assemble the following on a clean, uncluttered surface:

• Sterile bacteriostatic water. Not tap water, not distilled water, not sterile saline. See our primer on bacteriostatic water for why this matters.
• Lyophilised peptide vial. Inspect for cracks in the stopper or signs of moisture inside the vial before use.
• 30G or 31G insulin syringes. A 1 mL (100-unit) insulin syringe is the standard for drawing and later dosing. Some researchers prefer a separate, larger syringe (3 mL or 5 mL) for transferring bacteriostatic water during reconstitution, then use 30G insulin syringes for drawing working doses.
• Individually wrapped alcohol wipes. Isopropyl alcohol 70 percent, one per vial top.
• A clean, hard, non-porous work surface that has been wiped with alcohol. A tray or glass cutting board works. Avoid fabric, paper towel, or bare wood.
• A calculator or dosing reference. Do the maths before you touch the vial. Our peptide dosing calculator guide walks through the arithmetic.
• A fine-tip permanent marker for labelling.
• A sharps container for used needles.

Wash hands with soap and water before assembling the kit. If the workspace is shared, wipe it down with fresh 70 percent isopropyl before anything sterile comes out of its packaging. Minimise airflow: close windows, turn off ceiling fans, and keep pets out of the room.

Why Bacteriostatic Water Specifically#

The solvent choice is not a preference, it is part of the method. Bacteriostatic water for injection is sterile water containing 0.9 percent benzyl alcohol as a preservative. That preservative inhibits the growth of common bacteria, which allows a single vial of bacteriostatic water to be punctured and re-accessed over a window of approximately 28 days without becoming a microbial soup.

Plain sterile water for injection contains no preservative and is intended for single use; once the stopper is pierced, the contents should be treated as no longer sterile. Tap water and distilled water are not sterile at all and will introduce bacteria, endotoxins, and minerals into a peptide solution. Normal saline contains sodium chloride that can interact with certain peptides and is not the appropriate vehicle for most reconstitutions.

For Canadian researchers, Health Canada regulates bacteriostatic water as a pharmaceutical product, and it is typically sourced through compounding pharmacies or research suppliers alongside the peptide itself. The US FDA bacteriostatic water product label documents the 0.9 percent benzyl alcohol composition and the 28-day post-puncture window that underpins multi-dose use. Peer-reviewed work on peptide solution stability, including studies indexed in PubMed on the physical and chemical stability of therapeutic peptides in aqueous formulation, reinforces the same storage and handling principles. The full background on bacteriostatic water covers sourcing, shelf life, and the benzyl alcohol chemistry in detail.

Calculating Your Dilution#

Concentration is the research variable that makes every later dose meaningful. The formula is straightforward:

Concentration (mg/mL) = peptide mass (mg) divided by solvent volume (mL).

A worked example. A researcher has a 5 mg vial of BPC-157 and wants to reconstitute with 2 mL of bacteriostatic water. The resulting concentration is 5 mg divided by 2 mL, or 2.5 mg/mL. Translated into insulin-syringe units, a standard U-100 insulin syringe has 100 units across 1 mL, so each unit represents 0.025 mg (25 mcg) of peptide at this concentration. A 250 mcg dose would therefore be drawn as 10 units on the syringe.

Choosing the solvent volume is a judgement call. Larger volumes (for example 3 mL in a 5 mg vial) produce dilute solutions that are easier to measure for small doses but consume the vial faster because more fluid must be drawn per dose. Smaller volumes (1 mL in a 5 mg vial) produce concentrated solutions where a single unit covers a larger dose, which is useful for larger-volume peptides such as semaglutide but increases measurement error at small doses.

A sensible default for most 5 mg recovery peptides is 2 mL of bacteriostatic water. For a 5 mg vial of TB-500 that gives the same 2.5 mg/mL figure, and the insulin-syringe arithmetic transfers directly. Adjust to match the dose range the protocol calls for, and record the chosen ratio on the vial label.

How to Reconstitute Peptides: The Step-by-Step Workflow#

The following sequence assumes a standard lyophilised research peptide in a 2 mL or 3 mL glass vial with a rubber stopper and aluminium crimp. The same workflow applies regardless of peptide identity.

1. Wash hands and sanitise the work surface. Soap and water for at least 20 seconds, then a 70 percent isopropyl wipe over the tray, tools, and any outer packaging.
2. Let the peptide vial reach room temperature. Cold glass draws condensation and can build up static charge that makes powder cling to the stopper. Ten to fifteen minutes on the bench is usually enough.
3. Wipe both vial tops with fresh alcohol wipes. One wipe for the bacteriostatic water stopper, a separate wipe for the peptide vial stopper. Let the alcohol fully evaporate before piercing.
4. Draw the calculated volume of bacteriostatic water. Pull slightly more than needed, then tap out air bubbles and push back to the exact mark. For a 2 mL reconstitution, draw 2 mL on the larger syringe.
5. Insert the needle into the peptide vial at a 45-degree angle. Aim for the inner glass wall above the powder, not the powder itself. Depress the plunger slowly so the water runs down the wall of the vial. Direct impact on the lyophilised cake shears the peptide and can cause foaming.
6. Remove the needle. Do not shake the vial. Shaking denatures peptide chains and generates foam that is difficult to draw cleanly. Instead, swirl the vial gently between thumb and forefinger, or set it down and wait one to two minutes. Most peptides dissolve within seconds once water contacts the cake.
7. Inspect the solution. A properly reconstituted peptide is clear and colourless, or occasionally very faintly straw-coloured depending on the peptide. Cloudiness, visible particles, or stringy material means the peptide is degraded or contaminated. Discard the vial.
8. Label the vial. Peptide name, concentration in mg/mL, and reconstitution date. A fine-tip permanent marker on the glass or a small adhesive label works. Unlabelled vials in a shared fridge are a recipe for dosing mistakes.
9. Refrigerate immediately. The target temperature is 2 to 8 degrees Celsius, which is the standard domestic fridge range. Do not store on the door, where temperature fluctuates each time the fridge opens. Place the vial in the main body of the fridge, ideally inside a small opaque container to block light.

The entire sequence, from wiping stoppers to closing the fridge, should take between three and five minutes per vial once practised. Once a vial is reconstituted and labelled, the next question is where and how a subsequent research dose is delivered; our overview of subcutaneous injection sites covers the rotation patterns and anatomical considerations that complement clean reconstitution technique.

Common Mistakes#

Every failure mode below has been documented in research communities and in published compounding literature. Most are avoidable with deliberate technique.

• Shaking the vial to speed dissolution. Shear forces break peptide bonds. Swirl, do not shake.
• Injecting bacteriostatic water directly onto the powder. Aim for the glass wall. A powerful stream into the cake causes foaming and can aerosolise peptide into the headspace, where it is effectively lost.
• Using tap water, distilled water, or normal saline instead of bacteriostatic water. Tap and distilled are not sterile. Saline is not the standard vehicle and can interfere with certain peptides.
• Reconstituting on an unsanitised surface. Every airborne particle that lands on a punctured stopper is a potential contaminant.
• Reusing needles between vials, or between the bac water vial and the peptide vial with the same needle. One needle per puncture is the safer standard, and using separate needles for the water source and the peptide vial prevents cross-contamination of the bacteriostatic water stock.
• Forgetting to label. A clear liquid in a 2 mL vial is indistinguishable from any other clear liquid in a 2 mL vial. Name, concentration, and date go on every vial.
• Reconstituting vials you do not intend to use within the peptide's post-reconstitution window. A freshly mixed vial of BPC-157 does not last indefinitely. Mix what you need for the next few weeks, not every vial in the shipment.
• Piercing the stopper multiple times in the same spot. Rotate the injection point slightly each time to avoid coring rubber fragments into the solution.

Storage After Reconstitution#

Once a peptide is in solution, refrigeration is non-negotiable. The standard range is 2 to 8 degrees Celsius, matching a typical domestic fridge. Place the vial in an opaque container in the main body of the fridge, not on the door, and keep it away from the freezer compartment where temperatures can drop below zero and cause freeze-thaw damage.

Some peptides tolerate freezing for longer-term storage of reconstituted material; most do not. A conservative default is to refrigerate, not freeze, reconstituted peptides, and to only mix what will be used within the expected post-reconstitution window. Our peptide storage guide covers the specifics, including which peptides survive a single controlled freeze and which do not.

A practical habit for researchers working with multiple peptides: keep a small fridge-only tray dedicated to reconstituted vials, with labels facing forward, sorted oldest to newest. This reduces the chance of drawing from a stale vial during a rushed morning dosing routine.

How Long a Reconstituted Peptide Lasts#

The commonly cited figure is 30 days refrigerated. That number is a reasonable default for most research peptides and matches both the bacteriostatic water preservative window and the stability profile of typical peptide solutions at 2 to 8 degrees Celsius.

Actual shelf life varies by peptide:

• Peptides with short intrinsic half-lives in solution, such as BPC-157, may degrade meaningfully before the 30-day mark.
• Peptides engineered for stability, such as CJC-1295 with DAC and tesamorelin, often remain usable for longer.
• Larger, more chemically robust peptides like semaglutide and tirzepatide generally match or exceed the 30-day window.

The conservative approach is to plan a dosing protocol around a 28 to 30 day reconstituted lifetime, which also conveniently aligns with the bacteriostatic water preservative cycle. Vials past that point should be discarded, not stretched.

Checking for Degradation#

Before every draw, inspect the vial against a bright light. A healthy reconstituted peptide solution is clear or faintly tinted, with no visible particles, no cloudiness, and no strings or fibres suspended in the fluid.

Warning signs:

• Cloudiness or turbidity. Suggests microbial growth or peptide precipitation. Discard.
• Visible particulate. Small floating fragments, whether rubber cored from the stopper or precipitated peptide, indicate the vial is no longer usable for dosing.
• Colour change. A peptide that was clear at reconstitution and is now yellow, pink, or brown has degraded.
• Odour. Reconstituted peptide solutions should be essentially odourless aside from the faint benzyl alcohol note from the bac water. Anything sour, sulphurous, or otherwise off is a discard signal. Do not inhale deeply; a cautious sniff from a short distance is sufficient.

When in doubt, discard. Saving a suspect vial to avoid waste is a false economy against the risk of injecting degraded or contaminated material. Photographing questionable vials against a dark background before disposal creates a record that can be useful if a supplier batch shows a pattern of issues across multiple researchers, and it helps distinguish a reconstitution-technique problem from an upstream quality problem at the manufacturer or the compounding source.

Peptide-Specific Notes#

Most peptides follow the general workflow above without modification. A few have enough idiosyncrasies to warrant a short note.

Semaglutide and Tirzepatide#

GLP-1 class peptides such as semaglutide are typically reconstituted into larger volumes because the dose range is measured in milligrams rather than micrograms, and because researchers often work from multi-mg vials intended to last several weeks. Common ratios include 5 mg into 2 mL or 10 mg into 3 mL of bacteriostatic water. The reconstitution technique is identical to smaller peptides, but the larger draws at each dose mean researchers often use slightly lower-unit insulin syringes for measurement precision and inject slowly to reduce site irritation.

BPC-157#

BPC-157 is widely reported to have a shorter post-reconstitution shelf life than its stability in lyophilised form would suggest. Researchers working from larger vials sometimes reconstitute into smaller working portions or plan dosing so the full vial is consumed within two to three weeks. If protocols allow, reconstituting two separate 2.5 mg vials on a staggered schedule is more practical than mixing a single 5 mg vial and watching the back half degrade.

CJC-1295 with DAC#

CJC-1295 with DAC is engineered for extended in vivo half-life via its drug affinity complex, and reconstituted solutions are generally more stable than non-DAC GHRH analogues. Standard refrigeration applies, but researchers planning longer dosing cycles can more confidently work through a single reconstituted vial across the 30-day window. The same broadly applies to ipamorelin, which is a short peptide with good solution stability under refrigeration.

TB-500#

TB-500 reconstitutes cleanly and produces a clear solution at typical research concentrations. No special handling beyond the standard workflow is required, though researchers pairing it with BPC-157 in dual-vial protocols should label each vial clearly to avoid draw confusion.